Biology of the PancreasReviewBiology and Clinical Applications of Pancreatic Cancer Stem Cells
Section snippets
What are CSCs?
Although cancer cells have unrestrained proliferative capabilities and are resistant to apoptotic cues,1 only a limited number of cancer cells are actually capable of establishing tumors in immunodeficient mice. Built off of these observations, a cellular hierarchy was identified in hematopoietic malignancies, such as acute myelogenous leukemia and chronic myelogenous leukemia.2, 3 In these malignancies, a minority of cells identified based on specific cell-surface molecules (the CSCs), can
CD44, CD24, and ESA
The first population of PCSCs was described in 2007 by Li et al.7 Using tumor xenografts grown from patients' cancer cells, the authors studied the cell-surface markers CD44, CD24, and ESA, based on the CSC properties reported for CD44+/ESA+/CD24low cells from breast tumors.5 Sorting cells by single-, double-, or triple-positive or -negative status, Li et al found that CD44+/CD24+/ESA+ cells (which comprised 0.2%–0.8% of the cells in 10 tumors studied) were far more tumorigenic than other
Other Markers
Although the markers described are extracellular proteins that can be used in cell sorting, some internal markers and properties of PCSCs have been reported. A high level of aldehyde dehydrogenase 1 (ALDH1) activity has been associated with CSC function. A marker of normal and malignant breast stem cells33 and lung CSC,34 ALDH1 was associated with highly tumorigenic PDAC cells, regardless of CD133 status.35 Like c-Met and CD44, ALDH1 could be a functional marker of PCSCs. Studies suggest that
Signaling Pathways
Several markers have been used to define PCSCs, but the signaling pathways that regulate these markers have not been fully defined. Almost all PDACs contain activating mutations in K-Ras and have lost p16INK4A, and about half contain mutations in the tumor suppressors SMAD4 and p53.41 Stable genetic alterations might determine the properties (including surface marker profiles) of PCSCs, as observed in murine models for lung cancer,42 and could account for some of the differences observed in
Tumor Microenvironment
The tumor microenvironment comprises not only cancer cells that interact with each other, but also surrounding pancreatic cells, such as stellate cells, pan-endothelial cells, and infiltrating immune cells. These interactions promote tumor growth and progression, maintain the population of CSCs, and alter the stromal compartment to reduce the effects of chemotherapy. Although there are many cellular interactions involved in development of pancreatic cancer, we focus on interactions between
Targeting PCSCs
Most therapies for pancreatic cancer are aimed at debulking tumors, which comprise mostly differentiated tumor cells. These therapies, however, do not affect PCSCs, which can then re-establish tumors after treatment. Additionally, it is unclear whether some bulk tumor cells can de-differentiate into CSCs, similar to breast cancer cells during the EMT.52 New approaches are therefore needed to debulk existing tumors and eliminate PCSCs, to prevent relapse. Although no reagents have been tested to
Conclusions
The discovery of CSCs has introduced a number of interesting and important concepts to cancer biology, namely that only a select subset of cancer cells is tumorigenic, and that these cells are more resilient than bulk tumor cells, so they can re-establish tumors after treatment. As such, CSCs are one of the best targets for cancer treatment. However, we need to improve our understanding of PCSCs and pancreatic cancer biology to develop optimal treatment regimens. It is not clear how PCSCs
References (67)
- et al.
The hallmarks of cancer
Cell
(2000) - et al.
Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
Blood
(2002) - et al.
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Cell Stem Cell
(2007) - et al.
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth
Cell
(2010) - et al.
CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells
Blood
(1997) - et al.
Expression of CD44 confers a new adhesive phenotype on transfected cells
Cell
(1990) - et al.
Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met
J Biol Chem
(1999) - et al.
AC133/CD133/prominin-1
Int J Biochem Cell Biol
(2005) - et al.
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
Cell
(2005) - et al.
The chemokine receptor CXCR-4 is expressed on CD34+hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
Blood
(1998)
c-Met is a marker of pancreatic cancer stem cells and therapeutic target
Gastroenterology
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
Trends Cell Biol
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Cell Stem Cell
Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents
Gastroenterology
Primary tumor genotype is an important determinant in identification of lung cancer propagating cells
Cell Stem Cell
Notch-1 induces epithelial–mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells
Cancer Lett
The epithelial-mesenchymal transition generates cells with properties of stem cells
Cell
Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and β-catenin stabilization
Cancer Cell
Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells
Biochem Biophys Res Commun
Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer
Gastroenterology
Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy
Cell Stem Cell
Pancreatic stellate cells increase the invasion of human pancreatic cancer cells through the stromal cell-derived factor-1/CXCR4 Axis
Pancreatology
Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells
Gastroenterology
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
Nat Med
Stem cell gene expression programs influence clinical outcome in human leukemia
Nat Med
Prospective identification of tumorigenic breast cancer cells
Proc Natl Acad Sci U S A
Identification of a cancer stem cell in human brain tumors
Cancer Res
Identification of pancreatic cancer stem cells
Cancer Res
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma
Cancer Res
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens
Cancer Res
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Nature
Efficient tumour formation by single human melanoma cells
Nature
Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma
World J Gastroenterol
Cited by (88)
Cancer cells stemness: A doorstep to targeted therapy
2020, Biochimica et Biophysica Acta - Molecular Basis of DiseaseROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer
2019, Molecular Therapy OncolyticsCitation Excerpt :We found that 2-DG, a glycolytic inhibitor, partially abrogated GEM-induced expression of Nanog and Sox2 at protein and mRNA levels (Figures 2A and 2B). To confirm that the enhanced cancer cell stemness induced by GEM was glycolysis-dependent, we examined the expression of CD133, a CSC surface marker on PanCa cells.25,28,32,33 Treatment with 2-DG significantly decreased GEM-induced CD133 expression (Figures 2C and 2D).
Metabolism and epigenetics of pancreatic cancer stem cells
2019, Seminars in Cancer BiologySemaphorin 3 C enhances putative cancer stemness and accelerates peritoneal dissemination in pancreatic cancer
2023, Cancer Cell International
Conflicts of interest The authors disclose no conflicts.